Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
Phase 1
Terminated
- Conditions
- Breast CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Wiseman Research Initiatives LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00095862
- Locations
- 🇺🇸
Glendale Memorial Hospital Comprehensive Cancer Center, Glendale, California, United States
🇺🇸Hollywood Presbyterian Medical Center, Los Angeles, California, United States
News
No news found